Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

DREADD approach calms neuropsychiatric dread circuits in primates

Dec. 2, 2021

Small molecule allows targeted degradation of repeat expansion in vitro and in vivo in ALS models

Dec. 2, 2021

Glixogen Therapeutics identifies GLI1 inhibitors

Dec. 2, 2021

Tau is involved in the pathogenesis of ALS

Dec. 1, 2021

Locanabio AAV9 gene therapy constructs show promise for myotonic dystrophy type 1

Dec. 1, 2021

Resolvin D2 for treating Duchenne muscular dystrophy

Dec. 1, 2021

Roche patents new GABRA5 PAMs

Dec. 1, 2021

NP-10679 results in potent neuroprotection in preclinical models

Dec. 1, 2021

PQBP1 expression in microglia is important for tau-induced inflammation in the brain

Dec. 1, 2021

Eli Lilly and Company identifies CSF1R inhibitors

Nov. 30, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
Camp4 studies CMP-002 in SYNGAP1 haploinsufficient mouse model
BioWorld Science
Camp4 Therapeutics Corp. has highlighted new preclinical data for CMP-002, the company’s lead investigational antisense oligonucleotide (ASO) therapeutic...